All Vaccinology articles – Page 8
-
NewsShaping dairy farm vaccination decisions: social pressure and vet influence
A new study has identified key factors influencing vaccination intentions among Israeli dairy farmers, highlighting the impact of social pressure and need for improved communication between veterinarians and farmers to optimize voluntary vaccination programs.
-
NewsFear and vaccine hesitancy could fuel conspiracy beliefs, study finds
New research has shown that fear around vaccination can increase vaccine hesitancy, where conspiracy beliefs may then be used to justify not vaccinating, with these findings likely helping to inform more effective public health messaging.
-
NewsRVC awarded funding to investigate how methane-producing microbes colonise young calves
The Royal Veterinary College has been awarded £1,200,000 to explore how methane-producing microorganisms colonise the gastro-intestinal tract of calves in the first six weeks of life and how they impact the developing immune system.
-
NewsResearchers make breakthrough in bid to develop vaccines and drugs for neglected tropical disease
Scientists have developed a new, safe and effective way to infect volunteers with the parasite that causes leishmaniasis and measure the body’s immune response, bringing a vaccine for the neglected tropical disease a step closer.
-
NewsNovel nanosensing technique offers quality control of viral vectors in gene therapy
Researchers report a novel nanosensing technique to measure viral vector characteristics, measuring the ionic current that flows through a nanopore opening when a voltage differential is applied to a solution containing adeno-associated virus.
-
NewsValneva and LimmaTech team up to accelerate tetravalent Shigella vaccine candidate
Valneva SE and LimmaTech Biologics AG have entered into a strategic partnership and exclusive licensing agreement for the development, manufacturing and commercialization of Shigella4V (S4V), a tetravalent bioconjugate vaccine candidate against shigellosis.
-
NewsComprehensive meta-analysis pinpoints what vaccination strategies different countries should adopt
A new paper offers the first comprehensive meta-analysis examining what types of vaccine intervention strategies have the greatest effect, and whether different intervention strategies work better in different countries.
-
NewsNasal COVID-19 vaccine halts transmission
Next-generation Covid vaccines that target the virus’s points of entry — the nose and mouth — may be able to do what traditional shots cannot: contain the spread of respiratory infections and prevent transmission.
-
NewsIncidence of heart attacks and strokes found to be lower after COVID-19 vaccination
A new study involving nearly the whole adult population of England has found that the incidence of heart attacks and strokes was lower after COVID-19 vaccination than before or without vaccination.
-
News‘Russian doll’ packaging could boost drug delivery
Researchers have developed a new technology that lets them create compartments within compartments on the nanoscale, which can mean timing drug release for maximum effect at the site where it’s most needed.
-
NewsDespite risk, many unsure of temperature to heat food to prevent illness
With bird flu virus detected in cow’s milk, U.S. health authorities have warned the public against potential sources of exposure, including drinking raw or unpasteurized milk, and have reiterated a general warning that consuming uncooked or undercooked poultry or beef products can make you sick. Relatively few ...
-
News New initiative launched to advance mRNA vaccine development against human avian influenza (H5N1)
A new project aiming to accelerate the development and accessibility of human avian influenza (H5N1) messenger RNA (mRNA) vaccine candidates for manufacturers in low- and middle-income countries has been launched
-
NewsHIV vaccines tested in PrEPVacc fail to reduce infections
The results of the PrEPVacc HIV vaccine trial conducted in Eastern and Southern Africa, which ran between 2020 and 2024, show that neither of the two experimental vaccine regimens tested reduced HIV infections among the study population.
-
NewsStudy identifies unpredicted immune responses to adenoviral COVID vaccines
Researchers have identified unpredicted T-cell immune responses to the adenoviral (Oxford/AstraZeneca and Janssen) COVID-19 vaccines, but not to the mRNA vaccines.
-
NewsStudy shows promise for a universal influenza vaccine
New research reveals a promising approach to developing a universal influenza vaccine — a so-called “one and done” vaccine that confers lifetime immunity against an evolving virus.
-
NewsWhite paper explores innovative approaches to vaccine trials and pandemic preparedness
An international consortium of experts has created a white paper on innovative approaches for clinical vaccine research in order to be better prepared for future pandemics.
-
NewsScientists ID ‘unconventional’ new pathway for TB vaccines
Marginal zone B (MZB) cells are a natural response to TB infection which has been long overlooked - and which might be a welcome new target.
-
NewsJessica Kahn named Senior Associate Dean for Clinical and Translational Research at Albert Einstein College of Medicine
After an extensive national search, Jessica Kahn, M.D., M.P.H., has been appointed as the senior associate dean for clinical and translational research and director of the Block Institute for Clinical and Translational Research (ICTR) at Albert Einstein College of Medicine. Source: Cincinnati Children’s Hospital Jessica Kahn, M.D., M.P.H., ...
-
NewsNanoparticle vaccines enhance cross-protection against influenza viruses
To offer cross-protection against diverse influenza virus variants, nanoparticle vaccines can produce pivotal cellular and mucosal immune responses that enhance vaccine efficacy and broaden protection, a new study reveals.
-
NewsScientists discover how to improve vaccine responses to potentially deadly bacterium
Researchers have shown in an animal model that targeting a key suppressive immune molecule (IL-10) during the delivery of a vaccine improves the ability of the vaccine to protect against infection.